SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-027267
Filing Date
2019-12-31
Accepted
2019-12-31 14:12:52
Documents
2
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k123119_biondvaxpharma.htm 6-K 16764
2 NOTICE OF ANNUAL GENERAL MEETING f6k123119ex99-1_biond.htm EX-99.1 24270
  Complete submission text file 0001213900-19-027267.txt   42025
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 191319101
SIC: 2836 Biological Products, (No Diagnostic Substances)